# A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

> **NCT07028697** · PHASE3 · COMPLETED · sponsor: **Nxera Pharma Korea Co., Ltd.** · enrollment: 164 (actual)

## Conditions studied

- Insomnia Disorder

## Interventions

- **DRUG:** Daridorexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07028697
- **Lead sponsor:** Nxera Pharma Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-04
- **Primary completion:** 2025-09-23
- **Final completion:** 2025-10-21
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07028697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07028697, "A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07028697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*